Fundraising Fox
Palleon Pharmaceuticals
Waltham, US · Founded 2016 · 22 employees on LinkedIn · 7 known investors
Find your way into Palleon Pharmaceuticals
Sign up to see every warm intro you have to Palleon Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Palleon Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Palleon Pharma develops small molecule and biologic drugs targeting autoimmune and inflammatory diseases using proprietary glycoscience platforms. The company serves patients with conditions including systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune disorders.
Founders & leadership
Palleon Pharmaceuticals was founded in 2016 by Jim Broderick.
Board
Investors · 7
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · funding news · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: SR One Capital Management's portfolio page · board seat on SEC Form D · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$120.6M disclosed across 2 of 4 rounds · 2016–2020
- Undisclosed amountSeries AOct 2017Source ↗
▶$100MraisedSep 2020 · 7 investors · BiotechnologyRule 506(b)
- Karan TakharDirector
- William BurkothDirector
- Rajeev DadooDirector
- James W. BroderickExecutive Officer, Director
- John HennessyExecutive Officer
- Stephen HoffmanDirector
- Eric XiaoDirector
- Offering amount
- $100M
- Amount sold
- $100M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$20.6MraisedNov 2017 · 6 investors · BiotechnologyRule 506(b)
- John HennessyExecutive Officer
- Jens EcksteinDirector
- Karen HongDirector
- James W. BroderickExecutive Officer, Director
- James LeeDirector
- William BurkothDirector
- Stephen HoffmanDirector
- Offering amount
- $48.3M
- Amount sold
- $20.6M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Palleon Pharmaceuticals went on to found or lead other companies.
In the news
Frequently asked questions
- What does Palleon Pharmaceuticals do?
- Palleon Pharma develops small molecule and biologic drugs targeting autoimmune and inflammatory diseases using proprietary glycoscience platforms. The company serves patients with conditions including systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune disorders.
- Who founded Palleon Pharmaceuticals?
- Palleon Pharmaceuticals was founded by Jim Broderick in 2016.
- Who are Palleon Pharmaceuticals's investors?
- Palleon Pharmaceuticals's investors include Matrix Capital Management, Pfizer Ventures, Pfizer Venture Investments, SR One Capital Management, BioHealth Innovation, Inc., Takeda Ventures, Vertex Ventures HC.
- How much funding has Palleon Pharmaceuticals raised?
- Palleon Pharmaceuticals has disclosed $120.6M raised across 2 of its 4 known rounds.
- Where is Palleon Pharmaceuticals headquartered?
- Palleon Pharmaceuticals is headquartered in Waltham, US.